tiprankstipranks
Tenax negotiates global levosimendan rights, says Roth MKM
PremiumThe FlyTenax negotiates global levosimendan rights, says Roth MKM
2M ago
Tenax announces global license amendment, expands rights to levosimendan
PremiumThe Fly
Tenax announces global license amendment, expands rights to levosimendan
2M ago
Tenax Therapeutics Amends Global Rights Deal with Orion
PremiumCompany Announcements
Tenax Therapeutics Amends Global Rights Deal with Orion
2M ago
Tenax Therapeutics prices 1.6M shares at $5.65 in public offering
PremiumThe FlyTenax Therapeutics prices 1.6M shares at $5.65 in public offering
3M ago
Tenax Therapeutics Announces Pricing of Approximately $9 Million Public Offering
PremiumPress Releases
Tenax Therapeutics Announces Pricing of Approximately $9 Million Public Offering
3M ago
Tenax Therapeutics enrolls first patient in Phase 3 study of TNX-103
PremiumThe Fly
Tenax Therapeutics enrolls first patient in Phase 3 study of TNX-103
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100